Rhonda Patrick· PhD
Antibodies produced in response to common cold forms of coronavirus cross-neutralize SARS-CoV-2.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Antibodies produced in response to common cold forms of coronavirus cross-neutralize SARS-CoV-2.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
This suggests that the antibodies from these common cold coronaviruses may complicate accuracy of SARS-CoV-2 serological diagnostics as people reinfected with common cold coronaviruses could score as false positive with some SARS-CoV-2 serological assays.